Literature DB >> 30083786

The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review.

Zeinab Ashaari1, Mousa-Al-Reza Hadjzadeh1,2,3, Gholamreza Hassanzadeh4, Tahereh Alizamir2, Behpour Yousefi5,6, Zakieh Keshavarzi7, Tahmineh Mokhtari8,9.   

Abstract

Development and design of agents derived from natural sources with neuroprotective properties have received considerable attention. In the literature, it has been stated that these polyphenolic molecules have low adverse impacts and high efficacy when used in pathological conditions. Dietary flavonoids as a subgroup of polyphenols are bioactive products, extracted from several types of vegetables and fruits. Luteolin (3',4',5,7-tetrahydroxyflavone, LUT) is a widespread flavone known to have antioxidant and cytoprotective properties related to nuclear factor erythroid 2-related factor 2-(Nrf2) pathway. Extensive in vitro and in vivo investigations have indicated that LUT exhibits beneficial neuroprotective properties via different mechanisms. However, its psychopharmacological mechanisms are presently investigated in fewer studies. Therefore, we aimed to evaluate the neuroprotective impacts of LUT against central nervous system (CNS) disorders by reviewing available literature. Herein, we also reviewed the studies to understand the underlying mechanisms of LUT for curing CNS disorders.

Entities:  

Keywords:  Central nervous system; Disorders; Luteolin; Pharmacological mechanisms

Mesh:

Substances:

Year:  2018        PMID: 30083786     DOI: 10.1007/s12031-018-1094-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  122 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.

Authors:  Zuyi Weng; Arti B Patel; Smaro Panagiotidou; Theoharis C Theoharides
Journal:  J Allergy Clin Immunol       Date:  2014-12-10       Impact factor: 10.793

3.  Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression.

Authors:  Bhupinder Singh; Damanpreet Singh; Rajesh Kumar Goel
Journal:  J Ethnopharmacol       Date:  2011-11-15       Impact factor: 4.360

4.  Neuropharmacological evaluation of the putative anxiolytic effects of Passiflora edulis Sims, its sub-fractions and flavonoid constituents.

Authors:  Miguel Coleta; Maria Teresa Batista; Maria Graça Campos; Rui Carvalho; Maria Dulce Cotrim; Thereza Christina M de Lima; António Proença da Cunha
Journal:  Phytother Res       Date:  2006-12       Impact factor: 5.878

Review 5.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

Authors:  E Middleton; C Kandaswami; T C Theoharides
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

Review 6.  The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.

Authors:  Jeffrey A Johnson; Delinda A Johnson; Andrew D Kraft; Marcus J Calkins; Rebekah J Jakel; Marcelo R Vargas; Pei-Chun Chen
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

7.  Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin.

Authors:  Kristiana Kandere-Grzybowska; Duraisamy Kempuraj; Jing Cao; Curtis L Cetrulo; Theoharis C Theoharides
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

8.  RETRACTED: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice.

Authors:  Sachin P Patil; Pankaj D Jain; Jayant S Sancheti; Priya J Ghumatkar; Rufi Tambe; Sadhana Sathaye
Journal:  Neuropharmacology       Date:  2014-07-31       Impact factor: 5.250

Review 9.  Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models.

Authors:  Noemi Cardenas-Rodriguez; Bernardino Huerta-Gertrudis; Liliana Rivera-Espinosa; Hortencia Montesinos-Correa; Cindy Bandala; Liliana Carmona-Aparicio; Elvia Coballase-Urrutia
Journal:  Int J Mol Sci       Date:  2013-01-14       Impact factor: 5.923

10.  Luteolin inhibits SH-SY5Y cell apoptosis through suppression of the nuclear transcription factor-κB, mitogen-activated protein kinase and protein kinase B pathways in lipopolysaccharide-stimulated cocultured BV2 cells.

Authors:  Lihong Zhu; Wei Bi; Dan Lu; Chanjuan Zhang; Xiaoming Shu; Daxiang Lu
Journal:  Exp Ther Med       Date:  2014-02-20       Impact factor: 2.447

View more
  16 in total

Review 1.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

2.  Postoperative peritoneal adhesion: an update on physiopathology and novel traditional herbal and modern medical therapeutics.

Authors:  Setareh Soltany
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-09-26       Impact factor: 3.000

3.  Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis.

Authors:  Ester De Leo; Mohamed A Elmonem; Sante Princiero Berlingerio; Marine Berquez; Beatrice Paola Festa; Roberto Raso; Francesco Bellomo; Tobias Starborg; Manoe Jacoba Janssen; Zeinab Abbaszadeh; Sara Cairoli; Bianca Maria Goffredo; Rosalinde Masereeuw; Olivier Devuyst; Martin Lowe; Elena Levtchenko; Alessandro Luciani; Francesco Emma; Laura Rita Rega
Journal:  J Am Soc Nephrol       Date:  2020-06-05       Impact factor: 10.121

Review 4.  Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Mona Bawazeer
Journal:  Front Cell Neurosci       Date:  2019-08-02       Impact factor: 5.505

Review 5.  From Preclinical Stroke Models to Humans: Polyphenols in the Prevention and Treatment of Stroke.

Authors:  Edoardo Parrella; Cristina Gussago; Vanessa Porrini; Marina Benarese; Marina Pizzi
Journal:  Nutrients       Date:  2020-12-29       Impact factor: 5.717

6.  Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling.

Authors:  Luana Naia; Catarina M Pinho; Giacomo Dentoni; Jianping Liu; Nuno Santos Leal; Duarte M S Ferreira; Bernadette Schreiner; Riccardo Filadi; Lígia Fão; Niamh M C Connolly; Pontus Forsell; Gunnar Nordvall; Makoto Shimozawa; Elisa Greotti; Emy Basso; Pierre Theurey; Anna Gioran; Alvin Joselin; Marie Arsenian-Henriksson; Per Nilsson; A Cristina Rego; Jorge L Ruas; David Park; Daniele Bano; Paola Pizzo; Jochen H M Prehn; Maria Ankarcrona
Journal:  BMC Biol       Date:  2021-03-24       Impact factor: 7.431

7.  Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots.

Authors:  Dan Jin; Philippe Henry; Jacqueline Shan; Jie Chen
Journal:  Front Plant Sci       Date:  2021-07-01       Impact factor: 5.753

8.  Co-Ultramicronized Palmitoylethanolamide/Luteolin-Induced Oligodendrocyte Precursor Cell Differentiation is Associated With Tyro3 Receptor Upregulation.

Authors:  Laura Facci; Massimo Barbierato; Mariella Fusco; Pietro Giusti; Morena Zusso
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

9.  Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.

Authors:  Giuseppe Galvani; Nicola Mottolese; Laura Gennaccaro; Manuela Loi; Giorgio Medici; Marianna Tassinari; Claudia Fuchs; Elisabetta Ciani; Stefania Trazzi
Journal:  J Neuroinflammation       Date:  2021-07-08       Impact factor: 8.322

10.  Ameliorative effect of virgin olive oil against nephrotoxicity following sub-chronic administration of ethephon in male rats.

Authors:  Tahmineh Mokhtari; Hosam-Eldin Hussein Osman; Ayman El-Meghawry El-Kenawy; Nasrin Dashti
Journal:  J Tradit Complement Med       Date:  2019-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.